Humana Inc (NYSE:HUM) was downgraded by Zacks Investment Research from a “buy” rating to a “hold” rating in a note issued to investors on Tuesday. According to Zacks, “Humana’s continuous margin growth, accretive acquisitions, efficient capital deployment, business diversification initiatives and consistent revenue growth paved the way for long-term growth. The company’s earnings per share […]
